{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:20:37Z","timestamp":1762100437993,"version":"3.32.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ejphar.2005.09.039","type":"journal-article","created":{"date-parts":[[2005,11,9]],"date-time":"2005-11-09T12:15:49Z","timestamp":1131538549000},"page":"74-82","source":"Crossref","is-referenced-by-count":29,"title":["Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal \u03949-tetrahydrocannabinol"],"prefix":"10.1016","volume":"525","author":[{"given":"Diana L.","family":"Cichewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra P.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forrest L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.09.039_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.322.7295.1154","article-title":"Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain","volume":"322","author":"Allan","year":"2001","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.ejphar.2005.09.039_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cne.902960408","article-title":"Cutaneus trunci muscle reflex of the guinea pig","volume":"296","author":"Blight","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2005.09.039_bib3","series-title":"Statistics in Biology","first-page":"439","author":"Bliss","year":"1967"},{"key":"10.1016\/j.ejphar.2005.09.039_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/bja\/57.2.192","article-title":"Clinical actions of fentanyl and buprenorphine. The significance of receptor binding","volume":"57","author":"Boas","year":"1985","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2005.09.039_bib6","series-title":"Advances in Pain Research and Therapy","first-page":"233","article-title":"Transdermal drug delivery and its application to pain control","author":"Caplan","year":"1990"},{"key":"10.1016\/j.ejphar.2005.09.039_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","article-title":"Synergistic interactions between cannabinoid and opioid analgesics","volume":"74","author":"Cichewicz","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2005.09.039_bib8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/jpet.102.045575","article-title":"Antinociceptive synergy between delta(9)-tetrahydro-cannabinol and opioids after oral administration","volume":"304","author":"Cichewicz","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.09.039_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(24)38212-6","article-title":"Enhancement of mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose\u2013response analysis and receptor identification","volume":"289","author":"Cichewicz","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.09.039_bib10","series-title":"Lectures on Biostatistics: An Introduction to Statistics with Applications in Biology and Medicine","first-page":"327","author":"Colquhoun","year":"1971"},{"key":"10.1016\/j.ejphar.2005.09.039_bib11","series-title":"Regional Opioid Analgesia","first-page":"131","article-title":"Drugs","author":"De Castro","year":"1991"},{"key":"10.1016\/j.ejphar.2005.09.039_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001813-199504003-00007","article-title":"Transdermal fentanyl: a new step on the therapeutic ladder","volume":"6","author":"Donner","year":"1995","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejphar.2005.09.039_bib14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2165\/00003495-200363190-00003","article-title":"Transdermal buprenorphine","volume":"63","author":"Evans","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2005.09.039_bib15","first-page":"21","article-title":"Postoperative pain management using fentanyi patches in dogs","volume":"42","author":"Gilbert","year":"2003","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"10.1016\/j.ejphar.2005.09.039_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3959(89)90130-9","article-title":"The transdermal administration of fentanyi in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects","volume":"37","author":"Gourlay","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2005.09.039_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1006\/exnr.2000.7439","article-title":"Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury","volume":"164","author":"Hains","year":"2000","journal-title":"Exp. Neural."},{"key":"10.1016\/j.ejphar.2005.09.039_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/toxsci\/56.2.262","article-title":"Evaluation of percutaneous penetration of natural rubber latex proteins","volume":"56","author":"Hayes","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2005.09.039_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197917020-00001","article-title":"Buprenorphine: a review of its pharmacological properties and therapeutic efficacy","volume":"17","author":"Heel","year":"1979","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2005.09.039_bib20","first-page":"410","article-title":"The addition of dilute epinephrine produces equieffectiveness of bupivacaine enantiomers for cutaneous analgesia in the rat","volume":"91","author":"Khodorova","year":"2000","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2005.09.039_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/vr.138.6.128","article-title":"Clinical comparison of medetomidine with xylazine\/l-methadone in dogs","volume":"138","author":"Kramer","year":"1996","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ejphar.2005.09.039_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0014-2999(88)90543-2","article-title":"Buprenorphine is a potent\/cappa-opioid receptor antagonist in pigeons and mice","volume":"151","author":"Leander","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.09.039_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2005.09.039_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0740-5472(98)00028-2","article-title":"Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings","volume":"16","author":"Litten","year":"1999","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.ejphar.2005.09.039_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(99)00479-3","article-title":"Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception","volume":"378","author":"Mason","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.09.039_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/10673229309017075","article-title":"Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies","volume":"1","author":"Mello","year":"1993","journal-title":"Harv. Rev. Psychiatry."},{"key":"10.1016\/j.ejphar.2005.09.039_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1346-8138.1992.tb03197.x","article-title":"A new animal model for contact dermatitis: the hairless guinea pig","volume":"19","author":"Miyauchi","year":"1992","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.039_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/07367228309144546","article-title":"Suppression of bulboreticular unit responses to noxious stimuli by analgesic mesencephalic stimulation","volume":"1","author":"Morrow","year":"1983","journal-title":"Somatosens. Res."},{"key":"10.1016\/j.ejphar.2005.09.039_bib29","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.1998.16.4.1588","article-title":"Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine","volume":"16","author":"Payne","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2005.09.039_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2005.09.039_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-3057(98)00012-4","article-title":"The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol","volume":"60","author":"Smith","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2005.09.039_bib33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1023\/A:1016299824162","article-title":"A solubility and related physicochemical property comparison of buprenorphine and its 3-alkyl esters","volume":"12","author":"Stinchcomb","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2005.09.039_bib34","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2005.09.039_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(99)01908-3","article-title":"Synergistic interactions of endogenous opioids and cannabinoid systems","volume":"848","author":"Welch","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2005.09.039_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(03)00245-8","article-title":"Topical cannabinoid enhances topical morphine antinociception","volume":"105","author":"Yesilyurt","year":"2003","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905009556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905009556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T11:38:33Z","timestamp":1736077113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905009556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0014299905009556"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.09.039","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}